Content area
Full Text
[Image omitted] - (http://www.fiercebiotech.com/story/anna-protopapas-replaces-deborah-dunsire-millennium-oncology-head/2013-05-10)
Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here each Friday.
Anna Protopapas replaces Deborah Dunsire as Millennium oncology head
Millennium CEO Deborah Dunsire retired from her position at Takeda 's Millennium oncology unit, and Anna Protopapas took her place. Dunsire was a symbol of Takeda's transformation into a global pharma company, and she became the first female board member of Takeda after the company bought Millennium. Protopapas was formerly the business development chief at at the company. More (http://www.fiercebiotech.com/story/deborah-dunsire-exits-takeda-cuts-ceo-role-millennium-shakeup/2013-05-09)
Takeda Pharmaceutical, Millennium
Anna Protopapas will head Takeda's Millennium oncology business.
Eli Lilly
Derica W. Rice will temporarily replace CEO John C. Lechleiter.
Pharma
> Eli Lilly ($LLY) Chairman, President, and Chief Executive Officer John C. Lechleiter is taking a leave of absence from the company and...